Sat, Jul 26, 2014, 12:18 AM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Seattle Genetics Inc. Message Board

  • biogemfinder biogemfinder Jun 8, 2012 2:59 AM Flag

    Similar pattern to MITI before bouyout

    Volatility and then swift upswing indicates a buyout. However, since Clay went onto CNBC to tout the company's marketed drug Adcetris and its pipeline in all sorts of cancer, seems to me he is playin ghard ball with the potential suiters. If he thought the offers were serious enough and they were in "real" negotiation then I doubt he would be out there in CNBC and giving that kind of interview. With the Eu approval looming and sales number to be reported next month, I don;t think he will take any offer below #40 to be at all serious. I think he is holding out for more than $50 offer to even consider. he has seem what can happen vis a vis MITI MEDX etc.

 
SGEN
34.89+0.20(+0.58%)Jul 25 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.